相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival trends in young patients with Waldenstrom macroglobulinemia: Over five decades of experience
Karan L. Chohan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2023)
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia
Jorge J. Castillo et al.
LEUKEMIA (2022)
Autologous Haematopoietic Stem Cell Transplantation in Waldenstrom Macroglobulinemia: A Single-Centre 18-Year Experience
Suzanne O. Arulogun et al.
BLOOD (2021)
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML
Alexander D. Heini et al.
CANCERS (2021)
Second primary cancers in non-Hodgkin lymphoma: Family history and survival
Subhayan Chattopadhyay et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients
Barbara Jeker et al.
BONE MARROW TRANSPLANTATION (2020)
Acalabrutinib monotherapy in patients with Waldenstrom macroglobulinemia: a single-arm, multicentre, phase 2 study
Roger G. Owen et al.
LANCET HAEMATOLOGY (2020)
Younger patients with Waldenstrom Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
Marzia Varettoni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study
Constantine S. Tam et al.
BLOOD (2020)
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients
Irene Prediletto et al.
BONE MARROW TRANSPLANTATION (2019)
Waldenstrom's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Kastritis et al.
ANNALS OF ONCOLOGY (2018)
Fifty-Year Incidence of Waldenstrom Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review
Robert A. Kyle et al.
MAYO CLINIC PROCEEDINGS (2018)
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia
M. A. Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients
Stefanie Gilli et al.
ANNALS OF HEMATOLOGY (2017)
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials
Anat Gafter-Gvili et al.
HEMATOLOGICAL ONCOLOGY (2017)
Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History
Amit Sud et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML
V. Blum et al.
BONE MARROW TRANSPLANTATION (2017)
Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma
Martin D. Berger et al.
HEMATOLOGICAL ONCOLOGY (2016)
Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation
Yi-Bin Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
Darren M. Roberts et al.
JOURNAL OF AUTOIMMUNITY (2015)
CD34+selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma
Martin D. Berger et al.
LEUKEMIA RESEARCH (2015)
Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Overall survival and competing risks of death in patients with Waldenstrom macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database
Jorge J. Castillo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma
Giuseppe Visani et al.
BLOOD (2014)
Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers
Mohamad Mohty et al.
HAEMATOLOGICA (2014)
Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes
M. Makatsori et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)
Outcomes after 90Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis
Sophie Auger-Quittet et al.
CANCER MEDICINE (2014)
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu et al.
BLOOD (2013)
Response assessment in Waldenstrom macroglobulinaemia: update from the VIth International Workshop
Roger G. Owen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
BCNU-associated pneumonitis: portrait of a toxicity
Brian G. Till et al.
LEUKEMIA & LYMPHOMA (2012)
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant
Andrew A. Lane et al.
LEUKEMIA & LYMPHOMA (2012)
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients
Giuseppe Visani et al.
BLOOD (2011)
Autologous Stem Cell Transplantation as a Care Option in Waldenstrom's Macroglobulinemia
Saad Usmani et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
High-Dose Therapy and Autologous Stem-Cell Transplantation in Waldenstrom Macroglobulinemia: The Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
Christian Gisselbrecht et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
International prognostic scoring system for Waldenstrom macroglobulinemia
Pierre Morel et al.
BLOOD (2009)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia
NC Munshi et al.
SEMINARS IN ONCOLOGY (2003)
High-dose chemotherapy - High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia
A Anagnostopoulos et al.
BONE MARROW TRANSPLANTATION (2001)
分享论文
